Oberland Capital
Oberland Capital is a private investment firm, founded in 2013, that provides structured financing to companies across the global healthcare industry. The firm reports approximately $3.0–3.2 billion in assets under management and specializes in customized financing for clinical-stage and commercial-stage healthcare companies, using research-driven and quantitative methods. Oberland offers flexible capital solutions aimed at accelerating R&D, supporting commercialization, enabling acquisitions, and refinancing existing capital sources.
Industries
Nr. of Employees
small (1-50)
Oberland Capital
1700 Broadway, 37th Floor, New York, NY 10019
Portfolio
Referenced in site portfolio images and in a 28-Apr-2025 press announcement noting an investment up to $600 million by Oberland Capital.
#Not specified on source
Featured in site portfolio images and in a 13-Jan-2025 press announcement describing a debt refinancing and a strategic commercialization partnership supported by Oberland Capital.
#Not specified on source
Referenced in site portfolio images and in a 28-Apr-2025 press announcement noting an investment up to $600 million by Oberland Capital.
#Not specified on source
Featured in site portfolio images and in a 13-Jan-2025 press announcement describing a debt refinancing and a strategic commercialization partnership supported by Oberland Capital.
#Not specified on source